July 14, 2021: Check out interview of Dr. Selvakumar Naganathan - Clinical Lead - Liver transplantation and HPB surgery, Apollo Hospitals, Chennai. Check out the video and also excerpts of the inter...
July 13th 2021: A novel medication for people with a kind of liver cancer called hepatocellular carcinoma is available that appears to be better than standard therapy (HCC). The Food and Drug Administ...
On January 14, 2019, cabozantinib (CABOMETYX, Exelixis, Inc.) was approved by the Food and Drug Administration for patients with hepatocellular carcinoma (HCC) who have previously been treat...
Burden of liver cancer Liver cancer is a common malignant tumor accounting for more than half of the global liver cancer. The onset of hepatocellular carcinoma (HCC) is hidden, and early symptoms...
Liver cancer Liver cancer is currently the fifth most common cause of cancer-related death in the world. The current first-line systemic treatment drug is mainly sorafenib, but usually only prolongs ...
Cases of NK cell immunotherapy for advanced liver cancer 92-year-old advanced cancer patient has complete remission Seven years ago, Ms. M, who was in her 80s, was diagnosed with hepatocellular carcin...
Proton therapy for liver cancer, prolonged overall survival of patients with hepatocellular carcinoma proton therapyHepatocellular carcinoma is the most common type of liver cancer, with more than 700...
The incidence of liver cancer in China is very high, because liver cancer is difficult to find in the early stage of the disease. Once the diagnosis is often in the middle and late stages, the optimal...
Liver cancer is mainly caused by hbv, and middle-aged men are the main group of people with liver cancer. The stage of liver cancer is mainly divided into early, middle and late stages. It is relative...
For people around the age of 50, due to the degeneration of various organs of the body, if they are troubled by liver cirrhosis or fatty liver disease, they can easily turn into cancer and show sympto...